Health care's business class returned to its San Francisco sanctuary last week for JPMorgan's annual health care confab, at the gilded Westin St. Francis hotel on Union Square. After a two-year pandemic pause, the mood among the executives, bankers and startup founders in attendance had the aura of a reunion — as they gossiped about promotions, work-from-home routines, who's getting what investments. Dressed in their capitalist best — ranging from brilliant-blue or pastel-purple blazers to puffy-coat chic — they thronged to big parties held in art galleries and restaurants.
But the party was tinged with new anxiety: Would the big money invested in health care due to COVID-19 continue to flow? Would investors ask to see results — meaning profits — rather than just cool ideas?
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,